MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: docetaxel|DRUG: epirubicin hydrochloride|PROCEDURE: conventional surgery|PROCEDURE: dynamic contrast-enhanced magnetic resonance imaging|PROCEDURE: neoadjuvant therapy|PROCEDURE: radiomammography
Sponsor: Institut Bergonié